Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 100 participants.

Also called NCT05843682

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose health services research
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05843682
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05843682. Randomized; no masking; primary purpose health services research. Start 2022-10-07 (actual); primary completion 2023-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Technological Innovation in the Virtual Assistance of Patients With Uncontrolled Arterial Hypertension - Hyper 2
Acronym
Hyper2
Condition
Essential Hypertension
Condition
Metabolic Cardiovascular Syndrome
Condition
Heart Disease Risk Factors
Intervention (Device)
Using the Avatr App
Lead sponsor
University of Sao Paulo General Hospital (class: other)
Collaborator
InCor Heart Institute (class: other)

Record details

Record id
cardio:ct-nct05843682
Content hash
300f8e804e39aa9623ab5e3953a7044fdae2236d5a17d56c77c676b5d4faf655